Metalloprotease inhibitors
US6511993B1 · kind B1 · utility
73Cited by
0References
38Claims
0Family size
Inventors
Key dates
| Filing date | Jun 2, 2000 |
| Grant date | Jan 28, 2003 |
| Priority date | — |
| Expiry date | Jun 2, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of formula (I) and pharmaceutically-acceptable derivatives thereof, are matrix metalloprotease inhibitors, useful in treatment of conditions mediated by matrix metalloproteases, such as chronic dermal ulcers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.